[en] Pulmonary function tests, bronchoalveolar lavages, and venous blood samplings were performed 24 hours before and one hour after a standardized strenous treadmill exercise test on six horses suffering from chronic obstructive pulmonary disease (COPD) in clinical remission. Pulmonary function test consisted of the measurement of the mechanics of breathing and arterial blood gases analyses. During the exercise tests, heart and respiratory rates, and venous plasma lactate, pH and packed cell volume were controlled. Venous blood was analyzed for some markers of the oxidative stress, i.e., hemolysate glutathione redox ratio and oxidized glutathione, and plasma uric acid. BAL was analyzed for cell cytology as well as for markers of oxidative stress, i.e., glutathione redox ratio, and isoprostanes concentration. The procedure was repeated twice, i.e., before and after two IV injections of 40mg hyaluronate administered at seven day intervals. The results were compared to assess a possible influence of the treatment on the pulmonary and systemic inflammatory and/or oxidative status of these horses.
Hyaluronate did not influence the pulmonary function test or the physiological parameters recorded during exercise. There was a decrease in the percentage of BAL neutrophils after the treatment, suggesting a possible anti-inflammatory effect at the pulmonary level. As well, the concentration of isoprostanes in the pulmonary epithelium lining fluid was significantly lower after the treatment, which might be either a consequence of the decrease of the BAL neutrophils, or related to a possible antioxidant effect of the treatment. Lastly, the exercise-induced increase in plasma uric acid was significantly less marked after the treatment, which could be due to a systemic antioxidant effect of the hyaluronate.
In conclusion, this preliminary study brings some evidence that hyaluronate could have some antiinflammatory and antioxidant effects at the pulmonary—and systemic—level in COPD horses in remission. However, it does not help to understand the possible mechanisms underlying these observations. Further studies are now necessary to better understand its action, to assess the effect of the product on the pulmonary function of horses suffering from other respiratory problems as well as to assess the efficiency of other ways of administration, i.e., nebulization
Disciplines :
Veterinary medicine & animal health Anatomy (cytology, histology, embryology...) & physiology
Author, co-author :
Art, Tatiana ; Université de Liège - ULiège > Département de sciences fonctionnelles > Phys. neuro-muscul., de l'effort - Méd. sport. des animaux
Morris EA, Seeherman HJ: Clinical evaluation of poor performance in the racehorse: the results of 275 evaluations. Equine Vet J 1991;23:169-174.
Moore BR: Lower respiratory tract disease. Vet Clin North Am Equine Pract 1996;12:457-472.
Mills PC, Higgins AJ: Oxidant injury, nitric oxide and pulmonary vascular function: implications for the exercising horse. Vet J 1997;153:125-148.
Heffner JE, Repine JE: Pulmonary strategies of antioxidant defense. Am Rev Respir Dis 1989;140:531-554.
Repine JE, Bast A, Lankhorst I: Oxidative stress in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997;156:341-357.
Greenwald R, Moay W: Effect of oxygen-derived free radicals on hyaluronic acid. Arthritis Rheum 1980;23:455-463.
May S, Hooke R, Less P: Inhibition of interleukin-1 activity by equine synovial fluid. Equine Vet J 1992;24:99-102.
Kawcak CE, Frisbie DD, Trotter GW, McIlwraith CW, Gillette SM, Powers BE, Walton RM: Effects of intravenous administration of sodium hyaluronate on carpal joints in exercising horses after arthroscopic surgery and osteochondral fragmentation. Am J Vet Res 1997;58:1132-1140.
Art T, Duvivier DH, Votion D, Anciaux N, Vandenput S, Bayly WM, Lekeux P: Does an acute COPD crisis modify the cardiorespiratory and ventilatory adjustments to exercise in horses? J Appl Physiol 1998; 84:845-852.
Smith NC, Dunnett M, Mills PC: Simultaneous quantification of oxidised and reduced glutathione in equine biological fluids by reversed-phase high-performance liquid chromatography using electrochemical detection. J Chromatogr 1995;673:35-41.
Asheim A, Lindblad G: Intra-articular treatment of arthritis in race-horses with sodium hyaluronate. Acta Vet Scand 1976; 17:379-394.
Gaughan EM, Nixon A, Krook P, Yeager A, Mann K, Mohammed H, Bartel D: Effects of sodium hyaluronate on tendon healing and adhesion formation in horses. Am J Vet Res 1991;52:764-773.
Larsson K, Eklund A, Malmberg P, Bjermer L, Lundgren R, Belin L: Hyaluronic acid (hyaluronan) in BAL fluid distinguishes farmers with allergic alveolitis from farmers with asymptomatic alveolitis. Chest 1992;101: 109-114.
Tulamo R-M, Maisi P: Hyaluronate concentration in tracheal lavage fluid from clinically normal horses and horses with chronic obstructive pulmonary disease. Am J Vet Res 1997;58:729-732.
Morrow JD, Roberts LJ, II: The isoprostanes. Current knowledge and directions for future research. Biochem Pharmacol 1996;51:1-9.
Art T, Kirschvink N, Smith N, Roberts C, Duvivier DH, Votion D, Lekeux P: Indices of oxidative stress in blood and pulmonary epithelium lining fluid in horses suffering from recurrent airway obstruction. Equine Vet J, 1999;31:397-401.
Kirschvink N, Art T, Smith N, Lekeux P: Effect of exercise on isoprostane concentration in bronchoalveolar lavage fluid in COPD horses. 5th International Conference on Equine Exercise Physiology, Japan, September 1998.
Ward PA, Warren JS, Johnson KJ: Oxygen radicals, inflammation, and tissue injury. Free Radic Biol Med 1988;5:403-408.
Harris RC, Marlin DJ, Snow DH, Harkness RA: Muscle ATP loss and lactate accumulation at different work intensities in the exercising Thoroughbred horse. Eur J Appl Physiol 1991;62:235-244.
Sahlin K, Ekberg K, Cizinsky S: Changes in plasma hypoxanthine and free radical markers during exercise in man. Acta Physiol Scand 1991;142:275-281.
Becker BJ: Towards the physiological function of uric acid. Free Radic Biol Med 1993;14:615-631.
Moison RM, de Beaufort AJ, Haasnoot AA, Dubbelman TM: Uric acid and ascorbic acid redox ratios in plasma and tracheal aspirate of preterm babies with acute and chronic lung disease. Free Radic Biol Med 1997;23:226-234.